Print

IntriCon Corporation (IIN) Receives FDA 510(k) Marketing Clearance for Sirona (SIRO) Cardiac Diagnostic Monitor  
11/17/2011 6:30:57 AM

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced it has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA), for its Sirona Event and Holter Recorder. Sirona is the company’s second-generation cardiac diagnostic monitoring (CDM) device, allowing physicians to monitor patient cardiac events remotely.
//-->